J.POD®, our new advanced cGMP biomanufacturing facility, won the CPhI Pharma Awards 2022 for excellence in ‘Manufacturing, Technology and Equipment’. J.POD represents a paradigm shift in biologics manufacturing. Just-Evotec Biologics’ cutting-edge AI/ML protein design technologies combined with industry-leading intensified continuous bioprocess can help de-risk and accelerate biotherapeutics development from lead generation through to BLA while offering cost-effective and truly flexible clinical and commercial supply solutions.
Learn more about our future plans for J.POD in the interview now live on the CPHI website.